The context provided does not include specific information about individuals around 88 years old undergoing CAR-T cell therapy for multiple myeloma. However, CAR-T cell therapy has shown promising results in general, with many patients experiencing reduced cancer signs and symptoms. For personalized information, it's best read more

The context provided does not include specific information about individuals around 88 years old undergoing CAR-T cell therapy for multiple myeloma. However, CAR-T cell therapy has shown promising results in general, with many patients experiencing reduced cancer signs and symptoms. For personalized information, it's best to consult with your healthcare provider.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Myeloma Treatments: Risks and Benefits | MyMyelomaTeam